renal/urinary system
• with treatment of mice with an NK2 agonist prior to a 2-hour saline infusion, 84% of mutant mice displayed areflexic bladders compared to 28% of controls
|
• with treatment of mice with an NK2 agonist prior to a 2-hour saline infusion, 84% of mutant mice displayed overflow incontinence compared to 28% of controls
|
behavior/neurological
• F2rl1(PAR2)-agonist-induced hyperalgesia is not observed in mutants as is seen in wild-type mice
|